Buy the Book

Print This Topic Email This Topic

Pronunciations arthritis atherosclerosis chronic myelocytic leukemia fibrosis hemolysis megakaryocytes myelocytic myelocytic leukemia myelofibrosis myeloproliferative paresthesia polycythemia sarcoidosis sclerosis thrombocythemia thrombosis

Thrombocythemia (primary thrombocythemia) is a disorder in which excess platelets are produced, leading to abnormal blood clotting or bleeding.

• The cause is not known.
• The hands and feet may tingle, and the fingertips may feel cold.
• Routine blood tests usually provide a diagnosis, but sometimes a bone marrow biopsy is needed.
• Treatments that suppress symptoms and decrease platelet production are given.

Platelets (thrombocytes) are normally produced in the bone marrow by cells called megakaryocytes. In thrombocythemia, megakaryocytes increase in number and produce too many platelets.

Thrombocythemia affects about 2 to 3 of 100,000 people. It usually occurs in people older than 50 and more frequently in women. The cause of thrombocythemia is unknown.

Other Causes of a High Platelet Count When the cause of thrombocythemia is known, the disorder is called secondary thrombocythemia. Bleeding, removal of the spleen, infections, rheumatoid arthritis, certain cancers, premature destruction of red blood cells (hemolysis), iron deficiency, and sarcoidosis can cause secondary thrombocythemia. People with secondary thrombocythemia may have no symptoms related to the high number of platelets. Symptoms of the underlying condition usually dominate. When symptoms from a high number of platelets do occur, they are similar to those of primary thrombocythemia. Secondary thrombocythemia is diagnosed—and distinguished from primary thrombocythemia—when people with high platelet counts have a condition that readily accounts for the high number of platelets. Treatment is aimed at the cause. If the treatment is successful, the platelet count usually returns to normal.

Symptoms

Often, thrombocythemia does not produce symptoms. However, an excess of platelets can cause blood clots to form spontaneously, blocking the flow of blood through blood vessels, especially smaller ones but also in large vessels, including vessels in the brain, liver, and heart. Older people with thrombocythemia are much more likely to form clots than are younger people.

Symptoms are due to the blockage of blood vessels and may include tingling and other abnormal sensations in the hands and feet (paresthesias), cold fingertips, chest pain, vision changes, headaches, weakness, and dizziness. Bleeding, usually mild, may occur, often consisting of nosebleeds, easy bruising, slight oozing from the gums, or bleeding in the digestive tract. The spleen and liver may enlarge.

Diagnosis

Doctors make a diagnosis of thrombocythemia on the basis of the symptoms or after finding increased platelets during routine screening of the blood. Blood tests may be used to confirm the diagnosis. In addition, microscopic examination of the blood may reveal abnormally large platelets, clumps of platelets, and fragments of megakaryocytes.

To distinguish primary thrombocythemia, whose cause is unknown, from secondary thrombocythemia, which has a known cause, doctors look for signs of other conditions that could increase the platelet count. Removal of a sample of bone marrow for examination under a microscope (bone marrow biopsy—see Symptoms and Diagnosis of Blood Disorders: Bone Marrow Examination) is sometimes helpful and can exclude chronic myelocytic leukemia as a cause of an increased platelet count.

Spotlight on Aging Thrombocythemia is more likely to occur in older people. Older people are also more likely to have blockages of crucial large blood vessels, such as those in the heart and brain, because older people are more likely to have conditions, such as atherosclerosis, that also may result in blood vessel blockage. Older people are given the same drugs as younger people. They are able to tolerate the side effects fairly well. However, because older people may have other disorders and decreased marrow reserve, they may not be able to tolerate any therapy as well as younger people.

Treatment

Thrombocythemia may require treatment with a drug that decreases platelet production. Such drugs include hydroxyurea Some Trade Names
HYDREA
, anagrelide Some Trade Names
AGRYLIN
, and interferon-alpha. Treatment with one of these drugs is typically started when clotting complications develop. The age of the person, the other risks present, and previous history of forming blood clots (thrombosis) determine the need for such treatment. The drug is continued until the platelet count falls into a safe range. The dose must be adjusted to maintain an adequate number of platelets and other circulating cells. Small doses of aspirin Some Trade Names
BAYER
, which makes platelets less sticky and impairs clotting, may also be used.

If drug treatment does not slow platelet production quickly enough, it may be combined with or replaced by plateletpheresis, a procedure reserved for emergency situations. In this procedure, blood is withdrawn, platelets are removed from it, and the platelet-depleted blood is returned to the person.

Last full review/revision July 2008 by Josef T. Prchal, MD